| Melanoma |
1 |
1 |
| Skin Cancer |
0 |
0.8 |
| Tumor |
0 |
0.9 |
| Liver Tumor |
0 |
0.57 |
| Biologic Therapy |
0 |
0.33 |
| T-Lymphocyte |
0 |
0.25 |
| T-Cell Receptor |
0 |
0.24 |
| Genomic Medicine |
0 |
0.22 |
| Hepatocellular Carcinoma |
0 |
0.2 |
| Liver Metastases |
0 |
0.19 |
| Antiretroviral Therapy for HIV Infection |
0 |
0.16 |
| HIV Infection |
0 |
0.16 |
| New York |
0 |
0.16 |
| Nucleoside Reverse Transcriptase Inhibitors |
0 |
0.16 |
| Metastasis |
0 |
0.14 |
| Antigens |
0 |
0.08 |
| Cancer |
0 |
0.08 |
| Clinical Research |
0 |
0.08 |
| Europe |
0 |
0.08 |
| Health Care Quality, Access, and Evaluation |
0 |
0.08 |
| Liver |
0 |
0.08 |
| Oncogene |
0 |
0.08 |
| Receptors |
0 |
0.08 |
| Social Determinants of Health |
0 |
0.08 |